SEC Form 4 · accession 0001127602-17-001264
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James T Lenehan
Director
Period of report
Jan 5, 2017
Accepted (ET)
Jan 6, 2017 · 2:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jan 5, 2017 | M | 2,586 | $54.14 | A | 42,838 | D | |
| Ordinary Shares | Jan 5, 2017 | M | 801 | $54.14 | A | 43,639 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $54.14 | Jan 5, 2017 | M | 2,586 | D | — | Jan 18, 2017 | Ordinary Shares | 2,586 | 801 | D |
| Stock Option (Right to Buy)F2 | $54.14 | Jan 5, 2017 | M | 801 | D | — | Jan 18, 2017 | Ordinary Shares | 801 | 0 | D |
Explanation of responses
- F1This option to purchase 2,586 ordinary shares of New Medtronic for $54.14 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,586 Medtronic common stock shares for $54.14 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F2This option to purchase 801 New Medtronic ordinary shares for $54.14 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 801 Medtronic common stock shares for $54.14 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.